
KNI-1657 (KNI1657) is a highly мощный HIV-1 protease ингибитор (97% inhibition at 1 nM) with high sensitivity against lopinavir/ritonavir- or darunavir-resistant strains; inhibits wild-type HIV-1 (pNL4-3) and LPV-resistant strain A17 с IC50 of <3 and 25 nM, respectively.
KNI-1657 (KNI1657) is a highly potent HIV-1 protease inhibitor (97% inhibition at 1 nM) with high sensitivity against lopinavir/ritonavir- or darunavir-resistant strains; inhibits wild-type HIV-1 (pNL4-3) and LPV-resistant strain A17 with IC50 of <3 and 25 nM, respectively.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.